Marta Gehring

Aterovax SA develops in vitro diagnostic products for the management and assessment of cardiovascular diseases. Its products include diagnostic blood tests for determining and measuring activity of the cardiovascular biomarkers secretory phospholipase A2 (sPLA2) and secretory phospholipase A2-IIA (sPLA2-IIA) which provide physicians clinical information about the presence of a destabilized atherosclerotic plaque. The company was founded by Alain Tedgui, Ziad Mallat, Philippe Gabriel Steg, Joelle Benessiano and Jean-Marie Freyssinet on June 29, 2006 and is headquartered in Paris, France.

Laboratoires C.T.R.S. SAS is a French pharmaceutical company that manufactures pharmaceutical products. The company is based in Boulogne-Billancourt, France. The company was founded in 2002 by Bernard Deschamps. The CEO is Antoine Ferry.

Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France.

Gene Signal is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company's innovative therapies use precisely targeted angiogenic (inducing vascular growth) or angiostatic (inhibiting vascular growth) agents, derived from genes that are exclusively involved with the angiogenesis process . The firm's therapies aim to provide a more targeted alternative to existing solutions like Vascular Endothelial Growth Factors which impact other physiological phenomena in addition to angiogenesis. Gene Signal's targeted therapies represents a novel, next-generation approach to the management of angiogenesis based conditions and offer the potential to improve treatment options for concerned patients. Founded in 2000, Gene Signal has assembled an strong leadership team that includes scientific, medical, regulatory, and business professionals with successful track records in developing and bringing to market state of the art drugs. Gene Signal continues to develop its angiogenesis modulating technology and has built a significant intellectual property portfolio, as well as a robust clinical and preclinical pipeline.

Astra Zeneca Holding France SAS operates as a holding firm with interest in pharmaceuticals. The company was founded in 1994 and is headquartered in Rueil-Malmaison, France.

BASF France manufactures and markets coating products. The company is headquartered in Levallois-Perret, France.

Medtronic France SAS provides medical equipment and medical technology services. The company was founded by Earl Bakken and Palmer Hermundslie in 1949 and is headquartered in Boulogne-Billancourt, France.

Société Petroliere du Bec d'Ambes provides refrigerated storage facility services. The company is headquartered in Carbon-Blanc, France.

Actelion Pharmaceuticals, Inc. (France) is a private company based in Le Pin, France. and has subsidiaries in France. Actelion Pharmaceuticals, Inc. manufactures insulation materials. The French company was founded by Annick Schwebig.